Guillain-Barré syndrome following COVID-19: a newly emerging post-infectious complication.
- Resource Type
- Academic Journal
- Authors
- Webb S; Department of Intensive Care, St George's University Hospitals NHS Foundation Trust, London, UK silaswebb1@googlemail.com.; Wallace VC; Department of Neurology, St George's University Hospitals NHS Foundation Trust, London, UK.; Martin-Lopez D; Department of Neurophysiology, St George's University Hospitals NHS Foundation Trust, London, UK.; Yogarajah M; Department of Neurology, St George's University Hospitals NHS Foundation Trust, London, UK.
- Source
- Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101526291 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-790X (Electronic) Linking ISSN: 1757790X NLM ISO Abbreviation: BMJ Case Rep Subsets: MEDLINE
- Subject
- Language
- English
A 57-year-old man presented with a progressive flaccid symmetrical motor and sensory neuropathy following a 1-week history of cough and malaise. He was diagnosed with Guillain-Barré syndrome secondary to COVID-19 and started on intravenous immunoglobulin. He proceeded to have worsening respiratory function and needed intubation and mechanical ventilation. This is the first reported case of this rare neurological complication of COVID-19 in the UK, but it adds to a small but growing body of international evidence to suggest a significant association between these two conditions. Increasing appreciation of this by clinicians will ensure earlier diagnosis, monitoring and treatment of patients presenting with this.
Competing Interests: Competing interests: None declared.
(© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.)